2017-03-23,Ratings Changes Today
2017-03-21,USPTO Grants Composition Of Matter Patent To Achillion For Small Molecule Complement Alternative Pathway Factor D Inhibitors
2017-03-02,These 5 Stocks Under $10 Could Explode Up Soon
2017-02-28,Achillion Pharmaceuticals To Support A Natural History Study Of C3 Glomerulopathy, A Rare Renal Disorder, Conducted By Experts At Imperial College London
2017-02-24,Will Insiders Be Tempted To Buy More ACHN At The New 52-Week Low?
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-23,Achillion Reports 2016 Fourth Quarter And Year-End Financial Results
2017-02-13,Achillion To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-02-02,Premarket Biotech Movers: Cytokinetics, Achillion, Qiagen
2017-01-25,Notable Wednesday Option Activity: ACHN, RH, AJRD
2017-01-04,Don't Be Complacent About Complacency
2016-12-28,Achillion Announces Clinical Milestone For The Advancement Of JNJ-4178 In Phase 2B Development For Chronic HCV
2016-12-08,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-05,Data Presented At American Society Of Hematology Meeting Demonstrate Potential Advantages Of Factor D Inhibition For The Treatment Of Complement Alternative Pathway-Mediated Diseases
2016-11-30,Achillion Announces Initiation Of Patient Dosing By Janssen In A Global, Short Treatment-Duration Phase 2b Study Of JNJ-4178 In Chronic HCV
2016-11-03,Health Sector Down As Report of Industry Price Collusion Surfaces
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Achillion Announces Upcoming Presentations Of Novel Research Into Complement Biology At The 58th Annual Meeting Of The American Society Of Hematology
2016-11-03,Achillion Reports Third Quarter 2016 Financial Results And Provides Update On Clinical Programs
2016-11-02,Achillion To Present At The Credit Suisse 25th Annual Healthcare Conference
2016-10-31,Tax-Loss Selling Offers Stock-Picking Opportunities
2016-10-28,Achillion Pharmaceuticals Becomes Oversold (ACHN)
2016-10-25,First Week of ACHN June 2017 Options Trading
2016-09-23,Achillion Announces 100% SVR12 In The 6-Week And 8-Week Cohorts In Janssen's Phase 2 Trial Evaluating The Triple Combination Treatment Regimen Including Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-Naive HCV
2016-09-20,Interesting ACHN Put And Call Options For November 18th
2016-09-09,Achillion Announces 100% SVR Reported In Janssen's Phase 2a Trial Evaluating Triple Combination Of Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-Naive HCV
2016-09-06,Achillion Presents Novel Research On Factor D Inhibition At The XXVIth International Complement Workshop
2016-09-01,Achillion To Present At Two Upcoming Investor Conferences
2016-08-11,Achillion Announces Upcoming Presentation Of Interim Phase 2a Results From The Janssen Sponsored Trial Of Odalasvir, AL-335 And Simeprevir At The European Association For The Study Of The Liver (EASL) Special Conference
2016-08-09,Achillion To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-04,Achillion Reports Second Quarter 2016 Financial Results
2016-07-07,ACHN August 26th Options Begin Trading
2016-07-07,Achillion Pharmaceuticals (ACHN) Stock Up, JMP Upgrades
2016-07-07,Analysts' Actions -- First Solar, Qualcomm, Red Hat, Zions and More
2016-06-23,Interesting ACHN Put And Call Options For August 5th
2016-06-10,Achillion Presents Interim Phase 1 Results For ACH-4471, A Novel Orally-Administered Factor D Inhibitor, At The 21st Congress Of The European Hematology Association
2016-06-01,Achillion To Present At Three Upcoming Investor Conferences
2016-05-19,Achillion Announces Acceptance Of Late Breaking Abstract For ACH-4471 At The 21st Congress Of The European Hematology Association
2016-05-03,Achillion Reports First Quarter 2016 Financial Results And Provides Update On Clinical Programs
2016-04-28,Achillion To Present At The Deutsche Bank 41st Annual Health Care Conference
2016-03-04,Achillion Pharmaceuticals (ACHN) Weak On High Volume Today
2016-03-03,Achillion To Present At Two Upcoming Investor Conferences
2016-02-25,Achillion Reports 2015 Fourth Quarter And Year-End Financial Results
2016-02-11,Achillion Initiates Phase 1 Study Of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor
2016-02-08,Achillion To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-05,Achillion Pharmaceuticals is Now Oversold (ACHN)
2016-02-03,Achillion Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs
2016-01-26,Achillion Pharmaceuticals (ACHN) Weak On High Volume
2016-01-08,Achillion Pharmaceuticals (ACHN) Flagged As Strong On High Volume
2016-01-04,Achillion Appoints Dr. Joel Barrish As Chief Scientific Officer
2015-12-30,Trade-Ideas: Achillion Pharmaceuticals (ACHN) Is Today's Strong On High Relative Volume Stock
2015-12-16,Achillion Appoints Dr. Frank Verwiel To Board Of Directors
2015-12-14,Achillion Pharmaceuticals (ACHN) Is Today's Dead Cat Bounce Stock
2015-12-05,Achillion Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society Of Hematology And Nomination Of ACH-4471, A Novel Small Molecule Factor D Inhibitor, For Clinical Development
2015-11-23,Nothing for Bears to Get Excited About
2015-11-17,Lilly's Diabetes Drug Makes It a Turner Medical Fund Pick
2015-11-17,Achillion Pharmaceuticals (ACHN) Stock Has 40% Potential Upside
2015-11-09,Ratings Changes Today
2015-11-05,Achillion Reports Third Quarter And Nine Month 2015 Financial Results
2015-11-05,Achillion Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society Of Hematology Detailing Novel Results With Factor D Inhibitors
2015-11-02,Achillion To Present At The Credit Suisse 24th Annual Healthcare Conference
2015-10-16,Strong On High Relative Volume: Achillion Pharmaceuticals (ACHN)
2015-10-16,Achillion Announces That Janssen Has Initiated A Phase 2a Study To Evaluate The Combination Of AL-335, Odalasvir (ACH-3102), And Simeprevir For The Treatment Of Genotype 1 Chronic HCV
2015-09-18,Achillion Pharmaceuticals (ACHN) Highlighted As Today's Perilous Reversal Stock
2015-09-14,Commit To Purchase Achillion Pharmaceuticals At $7, Earn 36% Annualized Using Options
2015-09-01,Achillion To Present At Two Upcoming Investor Conferences
2015-08-18,Trade-Ideas: Achillion Pharmaceuticals (ACHN) Is Today's "Perilous Reversal" Stock
2015-08-17,Strong On High Volume: Achillion Pharmaceuticals (ACHN)
2015-08-10,Achillion Reports Second Quarter And Six Month 2015 Financial Results
2015-08-06,Achillion Pharmaceuticals Becomes Oversold (ACHN)
2015-08-05,August 5 Premarket Briefing: 10 Things You Should Know
2015-08-03,Achillion Announces That Janssen Has Initiated A Phase I Study To Evaluate The Effect Of Simeprevir And Odalasvir (ACH-3102) On AL-335 Pharmacokinetics
2015-07-14,Achillion Pharmaceuticals Stock Sees Short Interest Expand By 12.4%
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-06-18,Achillion To Present At The JMP Securities Life Sciences Conference 2015
2015-05-30,'Mad Money' Lightning Round: Sell, Sell, Sell Achillion Pharmaceuticals
2015-05-29,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-05-20,Stocks Struggle to Hold Gains as Market Processes Fed Minutes
2015-05-20,Stocks Rise as Banks Settle With DOJ, Crude Rallies
2015-05-20,Achillion Pharmaceuticals (ACHN) Stock Plummeting Following Ratings Cuts
2015-05-20,Analysts' Actions -- Achillion, Keurig Green Mountain, Lions Gate and More
2015-05-19,Achillion Enters Into Worldwide Collaboration For Hepatitis C With Janssen
2015-05-19,Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
2015-05-07,Achillion Reports First Quarter 2015 Financial Results
2015-05-05,May 5 Premarket Briefing: 10 Things You Should Know
2015-04-30,Achillion To Present At Two Upcoming Investor Conferences
2015-04-27,Achillion Pharmaceuticals Becomes Oversold
2015-04-25,Achillion Presents Detailed Clinical Results On ACH-3102 And ACH-3422 At The International Liver Congress
2015-04-08,Achillion Announces Upcoming Presentations At The International Liver Congress 2015 (EASL)
2015-03-21,'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets
2015-03-20,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-03-05,Achillion Pharmaceuticals (ACHN) Stock Tanking Today on Heavy Volume
2015-03-05,Achillion Pharmaceuticals Shares Cross Below 200 DMA
2015-03-05,Achillion Reports 2014 Fourth Quarter And Year-End Financial Results
2015-02-26,Develop Biotech 'Buy-Sell' Strategy
2015-02-18,Achillion Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
2015-02-11,Achillion Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-02-11,Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price
2015-02-11,'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM
2015-02-10,Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
2015-02-10,Achillion Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-02-09,Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More
2015-02-09,Achillion Achieves 100% SVR12 In Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102
2015-02-06,Achillion To Present At Two Upcoming Investor Conferences
2015-02-06,Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
2015-01-28,'Mad Money' Lightning Round: I'm Worried About Martin Midstream Partners
2015-01-27,Jim Cramer's 'Mad Money' Recap: Why Own Whiners When You Can Own Winners?
2015-01-06,Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
2015-01-02,One Reason Achillion Pharmaceuticals (ACHN) Stock is Rising Today
2015-01-02,Biotech Stocks 2014: The Best, Worst and Fastest-Growing
2014-12-24,February 2015 Options Now Available For Achillion Pharmaceuticals
2014-12-23,Dow Reaches Record Close as Santa Claus Rally Hits Day 5
2014-12-23,Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
2014-12-23,Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower
2014-12-23,Analysts' Actions: Achillion, Avon, Kimberly-Clark, Salesforce.com
2014-12-22,Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
2014-12-22,Achillion Shows Potential For "Best-in-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422
2014-12-18,Six Biotech and Technology Stocks With Strong Technical Set-Ups
2014-11-28,A Biotech With Enormous Potential
2014-11-26,ACHN January 2015 Options Begin Trading
2014-11-26,December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey
2014-11-25,Achillion To Present At Two Upcoming Investor Conferences
2014-11-20,Two Small-Cap Biotechnology Gems
2014-11-13,5 Momentum Stocks Currently on the Move with More Potential Upside
2014-11-12,Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
2014-11-10,Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting
2014-11-08,Achillion Reports 100% SVR12 In A Phase 2 Combination Study With ACH-3102 At The Liver Meeting 2014 (AASLD)
2014-11-06,ACHN December 26th Options Begin Trading
2014-11-06,Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform At The 56th Annual Meeting Of The American Society Of Hematology
2014-11-04,Achillion Pharmaceuticals (ACHN) Stock Falls on Lack of Hepatitis C Drug Data in Quarterly Earnings
2014-11-04,Achillion Reports Third Quarter And Nine Month 2014 Financial Results
2014-11-03,Super Important Biotech and Drug Stock Events for November
2014-10-28,Off the Charts
2014-10-22,Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
2014-10-17,Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback
2014-10-08,Achillion To Present Updated Clinical HCV Data On ACH-3102 And Preclinical Profile Of ACH-3422 At The American Association For The Study Of Liver Diseases (AASLD) Annual Meeting
2014-10-03,Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
2014-09-30,Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
2014-09-16,'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
2014-09-11,Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
2014-09-05,Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
2014-09-03,'Mad Money' Lightning Round: I'm Taking Verizon Over AT&T
2014-09-02,Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
2014-08-26,Achillion Pharmaceuticals (ACHN) Stock Hits New One-Year High
2014-08-26,'Fast Money' Recap: Next Stop, S&P 2,100?
2014-08-25,Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today
2014-08-19,Why Achillion Pharmaceuticals (ACHN) Stock Is Up in After-Hours Trading Today
2014-08-19,Achillion Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors
2014-08-18,Playing the New Hepatitis C Drugs
2014-08-18,3 Big Stocks on Traders' Radars
2014-08-18,Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today
2014-08-15,Why Achillion Pharmaceuticals (ACHN) Stock Surged to a One-Year High Today
2014-08-15,Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From An Eight Week Phase 2 Trial Evaluating A Ribavirin-Free Regimen Of ACH-3102 And Sofosbuvir For Genotype 1 HCV ("Proxy Study")
2014-08-12,ACHN November 22nd Options Begin Trading
2014-08-07,Achillion Reports Second Quarter And Six Month 2014 Financial Results
2014-07-25,3 Biotech Stocks Under $10 to Trade for Breakouts
2014-07-01,Achillion Pharmaceuticals Added To The Russell 2000 And Russell Microcap Indexes
2014-06-16,Why Achillion Pharmaceuticals (ACHN) Is Spiking Today
2014-06-11,4 Big Stocks on Traders' Radars
2014-06-11,Achillion Pharmaceuticals (ACHN) Stock Falls After Two Days of Gains
2014-06-11,Achillion To Present At Two Upcoming Investor Conferences
2014-06-10,Why Achillion Pharmaceuticals (ACHN) Stock Is Surging Today (Update)
2014-06-10,A Mixed Finish for Markets With No News to Tip Big Swings
2014-06-10,This Biotech Stock Could Be the Next Big Short Squeeze
2014-06-10,Are Achillion, Inovio Buyout Targets, Like Merck's Idenix?: StockTwits
2014-06-10,Achillion Hep C Drug Update is Well Timed
2014-06-10,Achillion Announces Initiation Of ACH-3422 Dosing In HCV-Infected Patients And Ability To Resume Sovaprevir Clinical Program For The Treatment Of Chronic HCV
2014-06-10,'Fast Money' Recap: Markets Start Another Week on Positive Note
2014-06-09,Why Achillion Pharmaceuticals (ACHN) Stock Is Up Today (Update)
2014-06-09,3 Big Stocks Everyone Is Talking About
2014-06-09,Achillion Pharma Might be Next Hep C Takeout Target
2014-05-07,Achillion Reports First Quarter 2014 Financial Results
2014-05-01,Achillion To Present At Three Upcoming Investor Conferences
2014-04-30,Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, For HCV
2014-04-14,First Week of April 19th Options Trading For Achillion Pharmaceuticals (ACHN)
2014-03-26,3 Biotech Stocks Under $10 to Trade
2014-03-14,Achillion Announces Oral Presentations Given At APASL 2014 Detailing Clinical Activity Of ACH-3102, Second-Generation NS5A Inhibitor, Against Genotype 1b HCV
2014-03-07,Achillion Reports 2013 Fourth Quarter And Year-End Financial Results
2014-03-04,Achillion Hasn't Stopped Aching
2017-03-23,Ratings Changes Today
2017-03-21,USPTO Grants Composition Of Matter Patent To Achillion For Small Molecule Complement Alternative Pathway Factor D Inhibitors
2017-03-02,These 5 Stocks Under $10 Could Explode Up Soon
2017-02-28,Achillion Pharmaceuticals To Support A Natural History Study Of C3 Glomerulopathy, A Rare Renal Disorder, Conducted By Experts At Imperial College London
2017-02-24,Will Insiders Be Tempted To Buy More ACHN At The New 52-Week Low?
2017-02-24,4 Biotech Stocks on the Move
2017-02-24,Biotech Movers: Cempra Flys High On Phase Three Results
2017-02-23,Achillion Reports 2016 Fourth Quarter And Year-End Financial Results
2017-02-13,Achillion To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-02-02,Premarket Biotech Movers: Cytokinetics, Achillion, Qiagen
2017-01-25,Notable Wednesday Option Activity: ACHN, RH, AJRD
2017-01-04,Don't Be Complacent About Complacency
2016-12-28,Achillion Announces Clinical Milestone For The Advancement Of JNJ-4178 In Phase 2B Development For Chronic HCV
2016-12-08,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-05,Data Presented At American Society Of Hematology Meeting Demonstrate Potential Advantages Of Factor D Inhibition For The Treatment Of Complement Alternative Pathway-Mediated Diseases
2016-11-30,Achillion Announces Initiation Of Patient Dosing By Janssen In A Global, Short Treatment-Duration Phase 2b Study Of JNJ-4178 In Chronic HCV
2016-11-03,Health Sector Down As Report of Industry Price Collusion Surfaces
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Achillion Announces Upcoming Presentations Of Novel Research Into Complement Biology At The 58th Annual Meeting Of The American Society Of Hematology
2016-11-03,Achillion Reports Third Quarter 2016 Financial Results And Provides Update On Clinical Programs
2016-11-02,Achillion To Present At The Credit Suisse 25th Annual Healthcare Conference
2016-10-31,Tax-Loss Selling Offers Stock-Picking Opportunities
2016-10-28,Achillion Pharmaceuticals Becomes Oversold (ACHN)
2016-10-25,First Week of ACHN June 2017 Options Trading
2016-09-23,Achillion Announces 100% SVR12 In The 6-Week And 8-Week Cohorts In Janssen's Phase 2 Trial Evaluating The Triple Combination Treatment Regimen Including Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-Naive HCV
2016-09-20,Interesting ACHN Put And Call Options For November 18th
2016-09-09,Achillion Announces 100% SVR Reported In Janssen's Phase 2a Trial Evaluating Triple Combination Of Odalasvir, AL-335, And Simeprevir For Genotype 1 Treatment-Naive HCV
2016-09-06,Achillion Presents Novel Research On Factor D Inhibition At The XXVIth International Complement Workshop
2016-09-01,Achillion To Present At Two Upcoming Investor Conferences
2016-08-11,Achillion Announces Upcoming Presentation Of Interim Phase 2a Results From The Janssen Sponsored Trial Of Odalasvir, AL-335 And Simeprevir At The European Association For The Study Of The Liver (EASL) Special Conference
2016-08-09,Achillion To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-04,Achillion Reports Second Quarter 2016 Financial Results
2016-07-07,ACHN August 26th Options Begin Trading
2016-07-07,Achillion Pharmaceuticals (ACHN) Stock Up, JMP Upgrades
2016-07-07,Analysts' Actions -- First Solar, Qualcomm, Red Hat, Zions and More
2016-06-23,Interesting ACHN Put And Call Options For August 5th
2016-06-10,Achillion Presents Interim Phase 1 Results For ACH-4471, A Novel Orally-Administered Factor D Inhibitor, At The 21st Congress Of The European Hematology Association
2016-06-01,Achillion To Present At Three Upcoming Investor Conferences
2016-05-19,Achillion Announces Acceptance Of Late Breaking Abstract For ACH-4471 At The 21st Congress Of The European Hematology Association
2016-05-03,Achillion Reports First Quarter 2016 Financial Results And Provides Update On Clinical Programs
2016-04-28,Achillion To Present At The Deutsche Bank 41st Annual Health Care Conference
2016-03-04,Achillion Pharmaceuticals (ACHN) Weak On High Volume Today
2016-03-03,Achillion To Present At Two Upcoming Investor Conferences
2016-02-25,Achillion Reports 2015 Fourth Quarter And Year-End Financial Results
2016-02-11,Achillion Initiates Phase 1 Study Of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor
2016-02-08,Achillion To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-05,Achillion Pharmaceuticals is Now Oversold (ACHN)
2016-02-03,Achillion Announces Appointments Of Martha Manning As General Counsel And Amy Jennings As Head Of Regulatory Affairs
2016-01-26,Achillion Pharmaceuticals (ACHN) Weak On High Volume
2016-01-08,Achillion Pharmaceuticals (ACHN) Flagged As Strong On High Volume
2016-01-04,Achillion Appoints Dr. Joel Barrish As Chief Scientific Officer
2015-12-30,Trade-Ideas: Achillion Pharmaceuticals (ACHN) Is Today's Strong On High Relative Volume Stock
2015-12-16,Achillion Appoints Dr. Frank Verwiel To Board Of Directors
2015-12-14,Achillion Pharmaceuticals (ACHN) Is Today's Dead Cat Bounce Stock
2015-12-05,Achillion Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society Of Hematology And Nomination Of ACH-4471, A Novel Small Molecule Factor D Inhibitor, For Clinical Development
2015-11-23,Nothing for Bears to Get Excited About
2015-11-17,Lilly's Diabetes Drug Makes It a Turner Medical Fund Pick
2015-11-17,Achillion Pharmaceuticals (ACHN) Stock Has 40% Potential Upside
2015-11-09,Ratings Changes Today
2015-11-05,Achillion Reports Third Quarter And Nine Month 2015 Financial Results
2015-11-05,Achillion Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society Of Hematology Detailing Novel Results With Factor D Inhibitors
2015-11-02,Achillion To Present At The Credit Suisse 24th Annual Healthcare Conference
2015-10-16,Strong On High Relative Volume: Achillion Pharmaceuticals (ACHN)
2015-10-16,Achillion Announces That Janssen Has Initiated A Phase 2a Study To Evaluate The Combination Of AL-335, Odalasvir (ACH-3102), And Simeprevir For The Treatment Of Genotype 1 Chronic HCV
2015-09-18,Achillion Pharmaceuticals (ACHN) Highlighted As Today's Perilous Reversal Stock
2015-09-14,Commit To Purchase Achillion Pharmaceuticals At $7, Earn 36% Annualized Using Options
2015-09-01,Achillion To Present At Two Upcoming Investor Conferences
2015-08-18,Trade-Ideas: Achillion Pharmaceuticals (ACHN) Is Today's "Perilous Reversal" Stock
2015-08-17,Strong On High Volume: Achillion Pharmaceuticals (ACHN)
2015-08-10,Achillion Reports Second Quarter And Six Month 2015 Financial Results
2015-08-06,Achillion Pharmaceuticals Becomes Oversold (ACHN)
2015-08-05,August 5 Premarket Briefing: 10 Things You Should Know
2015-08-03,Achillion Announces That Janssen Has Initiated A Phase I Study To Evaluate The Effect Of Simeprevir And Odalasvir (ACH-3102) On AL-335 Pharmacokinetics
2015-07-14,Achillion Pharmaceuticals Stock Sees Short Interest Expand By 12.4%
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-06-18,Achillion To Present At The JMP Securities Life Sciences Conference 2015
2015-05-30,'Mad Money' Lightning Round: Sell, Sell, Sell Achillion Pharmaceuticals
2015-05-29,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-05-20,Stocks Struggle to Hold Gains as Market Processes Fed Minutes
2015-05-20,Stocks Rise as Banks Settle With DOJ, Crude Rallies
2015-05-20,Achillion Pharmaceuticals (ACHN) Stock Plummeting Following Ratings Cuts
2015-05-20,Analysts' Actions -- Achillion, Keurig Green Mountain, Lions Gate and More
2015-05-19,Achillion Enters Into Worldwide Collaboration For Hepatitis C With Janssen
2015-05-19,Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
2015-05-07,Achillion Reports First Quarter 2015 Financial Results
2015-05-05,May 5 Premarket Briefing: 10 Things You Should Know
2015-04-30,Achillion To Present At Two Upcoming Investor Conferences
2015-04-27,Achillion Pharmaceuticals Becomes Oversold
2015-04-25,Achillion Presents Detailed Clinical Results On ACH-3102 And ACH-3422 At The International Liver Congress
2015-04-08,Achillion Announces Upcoming Presentations At The International Liver Congress 2015 (EASL)
2015-03-21,'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets
2015-03-20,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-03-05,Achillion Pharmaceuticals (ACHN) Stock Tanking Today on Heavy Volume
2015-03-05,Achillion Pharmaceuticals Shares Cross Below 200 DMA
2015-03-05,Achillion Reports 2014 Fourth Quarter And Year-End Financial Results
2015-02-26,Develop Biotech 'Buy-Sell' Strategy
2015-02-18,Achillion Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
2015-02-11,Achillion Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2015-02-11,Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price
2015-02-11,'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM
2015-02-10,Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
2015-02-10,Achillion Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-02-09,Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More
2015-02-09,Achillion Achieves 100% SVR12 In Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102
2015-02-06,Achillion To Present At Two Upcoming Investor Conferences
2015-02-06,Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
2015-01-28,'Mad Money' Lightning Round: I'm Worried About Martin Midstream Partners
2015-01-27,Jim Cramer's 'Mad Money' Recap: Why Own Whiners When You Can Own Winners?
2015-01-06,Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
2015-01-02,One Reason Achillion Pharmaceuticals (ACHN) Stock is Rising Today
2015-01-02,Biotech Stocks 2014: The Best, Worst and Fastest-Growing
2014-12-24,February 2015 Options Now Available For Achillion Pharmaceuticals
2014-12-23,Dow Reaches Record Close as Santa Claus Rally Hits Day 5
2014-12-23,Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
2014-12-23,Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower
2014-12-23,Analysts' Actions: Achillion, Avon, Kimberly-Clark, Salesforce.com
2014-12-22,Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
2014-12-22,Achillion Shows Potential For "Best-in-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422
2014-12-18,Six Biotech and Technology Stocks With Strong Technical Set-Ups
2014-11-28,A Biotech With Enormous Potential
2014-11-26,ACHN January 2015 Options Begin Trading
2014-11-26,December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey
2014-11-25,Achillion To Present At Two Upcoming Investor Conferences
2014-11-20,Two Small-Cap Biotechnology Gems
2014-11-13,5 Momentum Stocks Currently on the Move with More Potential Upside
2014-11-12,Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
2014-11-10,Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting
2014-11-08,Achillion Reports 100% SVR12 In A Phase 2 Combination Study With ACH-3102 At The Liver Meeting 2014 (AASLD)
2014-11-06,ACHN December 26th Options Begin Trading
2014-11-06,Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform At The 56th Annual Meeting Of The American Society Of Hematology
2014-11-04,Achillion Pharmaceuticals (ACHN) Stock Falls on Lack of Hepatitis C Drug Data in Quarterly Earnings
2014-11-04,Achillion Reports Third Quarter And Nine Month 2014 Financial Results
2014-11-03,Super Important Biotech and Drug Stock Events for November
2014-10-28,Off the Charts
2014-10-22,Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
2014-10-17,Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback
2014-10-08,Achillion To Present Updated Clinical HCV Data On ACH-3102 And Preclinical Profile Of ACH-3422 At The American Association For The Study Of Liver Diseases (AASLD) Annual Meeting
2014-10-03,Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
2014-09-30,Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
2014-09-16,'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
2014-09-11,Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
2014-09-05,Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
2014-09-03,'Mad Money' Lightning Round: I'm Taking Verizon Over AT&T
2014-09-02,Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
2014-08-26,Achillion Pharmaceuticals (ACHN) Stock Hits New One-Year High
2014-08-26,'Fast Money' Recap: Next Stop, S&P 2,100?
2014-08-25,Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today
2014-08-19,Why Achillion Pharmaceuticals (ACHN) Stock Is Up in After-Hours Trading Today
2014-08-19,Achillion Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors
2014-08-18,Playing the New Hepatitis C Drugs
2014-08-18,3 Big Stocks on Traders' Radars
2014-08-18,Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today
2014-08-15,Why Achillion Pharmaceuticals (ACHN) Stock Surged to a One-Year High Today
2014-08-15,Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From An Eight Week Phase 2 Trial Evaluating A Ribavirin-Free Regimen Of ACH-3102 And Sofosbuvir For Genotype 1 HCV ("Proxy Study")
2014-08-12,ACHN November 22nd Options Begin Trading
2014-08-07,Achillion Reports Second Quarter And Six Month 2014 Financial Results
2014-07-25,3 Biotech Stocks Under $10 to Trade for Breakouts
2014-07-01,Achillion Pharmaceuticals Added To The Russell 2000 And Russell Microcap Indexes
2014-06-16,Why Achillion Pharmaceuticals (ACHN) Is Spiking Today
2014-06-11,4 Big Stocks on Traders' Radars
2014-06-11,Achillion Pharmaceuticals (ACHN) Stock Falls After Two Days of Gains
2014-06-11,Achillion To Present At Two Upcoming Investor Conferences
2014-06-10,Why Achillion Pharmaceuticals (ACHN) Stock Is Surging Today (Update)
2014-06-10,A Mixed Finish for Markets With No News to Tip Big Swings
2014-06-10,This Biotech Stock Could Be the Next Big Short Squeeze
2014-06-10,Are Achillion, Inovio Buyout Targets, Like Merck's Idenix?: StockTwits
2014-06-10,Achillion Hep C Drug Update is Well Timed
2014-06-10,Achillion Announces Initiation Of ACH-3422 Dosing In HCV-Infected Patients And Ability To Resume Sovaprevir Clinical Program For The Treatment Of Chronic HCV
2014-06-10,'Fast Money' Recap: Markets Start Another Week on Positive Note
2014-06-09,Why Achillion Pharmaceuticals (ACHN) Stock Is Up Today (Update)
2014-06-09,3 Big Stocks Everyone Is Talking About
2014-06-09,Achillion Pharma Might be Next Hep C Takeout Target
2014-05-07,Achillion Reports First Quarter 2014 Financial Results
2014-05-01,Achillion To Present At Three Upcoming Investor Conferences
2014-04-30,Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, For HCV
2014-04-14,First Week of April 19th Options Trading For Achillion Pharmaceuticals (ACHN)
2014-03-26,3 Biotech Stocks Under $10 to Trade
2014-03-14,Achillion Announces Oral Presentations Given At APASL 2014 Detailing Clinical Activity Of ACH-3102, Second-Generation NS5A Inhibitor, Against Genotype 1b HCV
2014-03-07,Achillion Reports 2013 Fourth Quarter And Year-End Financial Results
2014-03-04,Achillion Hasn't Stopped Aching
